4D Molecular Therapeutics, Inc. (FDMT)
11.45
+0.53
(+4.85%)
USD |
NASDAQ |
Dec 12, 10:31
4D Molecular Therapeutics Shareholders Equity (Quarterly): 368.98M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Aura Biosciences, Inc. | 156.67M |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
| Palatin Technologies, Inc. | 0.3964M |
| Theriva Biologics, Inc. | 6.738M |
| Oragenics, Inc. | 9.831M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 423.98M |
| Total Liabilities (Quarterly) | 55.00M |
| Debt to Equity Ratio | 0.0603 |
| Current Ratio | 8.418 |
| Net Debt Paydown Yield | -0.42% |